Categories: Health

AstraZeneca India receives marketing approval for Osimertinib

<p>
<strong>Pharmaceutical company AstraZeneca India on Wednesday announced that it has received marketing approval for Tagrisso (Osimertinib) for adjuvant treatment after complete tumour resection in patients with non-small cell lung cancer (NSCLC), whose tumours have epidermal growth factor receptor (EGFR) mutations.</strong></p>
<p>
Osimertinib, a once daily oral pill, when given to patients of lung cancer whose tumour has a specific mutation called EGFR mutation and who have undergone surgical removal of the lung tumour, has shown to decrease the risk of cancer recurrence by nearly 83 per cent in the ADAURA clinical trial in early stage lung cancer patients, the company said in a statement.<br />
<br />
"AstraZeneca has always been and will continue to bring forward world-class treatment solutions for non-communicable diseases," said Gagandeep Singh Bedi, Managing Director, AstraZeneca India.<br />
<br />
"The regulatory approval of Tagrisso (Osimertinib) in India will provide better medicine for the management of Non-Small Cell Lung Cancer and help patients attain a better quality of life," Bedi added.<br />
<br />
Osimertinib is the first targeted oral treatment option to show such a significant benefit in terms of cancer free survival in early lung cancers with EGFRm positivity.<br />
<br />
Cancer spread to the brain and other organs is one of the important cause of recurrence in early stage lung cancer. Osimertinib has shown to decrease the chances of cancer spreading to the brain & other distant organs.<br />
<br />
According to the Global Cancer Survey (GLOBOCAN), in 2018, the total number of new lung cancer cases was 67,795 and 63,475 deaths were reported, making lung cancer a very aggressive and devastating cancer.</p>
<p>
<em>(IANS)</em></p>

India Narrative

Recent Posts

Indian Chamber of Commerce hosts 14th India Minerals and Metals Forum, focuses on green steel and circular economy

The Indian Chamber of Commerce (ICC) on Thursday hosted the 14th India Minerals and Metals…

6 hours ago

PM Modi concludes visit to Ghana, heads to Trinidad & Tobago for 2nd leg of five-nation tour

Prime Minister Narendra Modi departed from Ghana's capital city of Accra after concluding the first…

6 hours ago

India-Australia science and technology project set to boost undersea surveillance capabilities

India and Australia have undertaken the first science and technology project arrangement to improve the…

11 hours ago

India-France joint military Exercise Shakti-VIII concludes, marks completion of intensive training engagement

The eighth edition of India-France Joint Military Exercise Shakti-VIII concluded on Thursday at Camp Larzac,…

11 hours ago

Recognition of his steadfast efforts in strengthening voice of Global South: Jaishankar as PM Modi receives Ghana’s highest state honour

As Prime Minister Narendra Modi has been conferred the national honour of Ghana, Officer of…

14 hours ago

Jaishankar meets with FBI Director Kash Patel; appreciates India-US cooperation in countering terrorism, organised crime

External Affairs Minister S Jaishankar held a meeting with FBI Director Kash Patel in Washington…

14 hours ago